Offer - Urjas Oil for just ₹ 1
Viraferonpeg Redi, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Hepatitis C. The alternative uses of Viraferonpeg Redi have also been explained below.
The optimal dosage of Viraferonpeg Redi is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Viraferonpeg Redi as well, which are listed below. These side effects of Viraferonpeg Redi are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Viraferonpeg Redi's effect during pregnancy is Moderate and Unknown while nursing. Further, the section on Viraferonpeg Redi related warnings talks about Viraferonpeg Redi's effects on the liver, heart and kidney.
Viraferonpeg Redi is contraindicated in people with pre-existing medical conditions like Suicidal Tendency, Heart Disease, Kidney Disease as it can result in adverse effects. The section on Viraferonpeg Redi contraindications lists all such conditions.
Drug reaction of Viraferonpeg Redi with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Viraferonpeg Redi is considered not safe while driving, and is not addictive.
Viraferonpeg Redi is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Viraferonpeg Redi safe for pregnant women?
Viraferonpeg Redi may have some side effects during pregnancy. Pregnant women should discontinue the use of Viraferonpeg Redi, and talk to their doctor, if they notice any discomfort.
Is the use of Viraferonpeg Redi safe during breastfeeding?
No research work has been carried out till date on effect of Viraferonpeg Redi on breastfeeding women. So it is not known whether taking Viraferonpeg Redi will cause side effects or not.
What is the effect of Viraferonpeg Redi on the Kidneys?
Very few cases of side effects of Viraferonpeg Redi on kidney have been reported.
What is the effect of Viraferonpeg Redi on the Liver?
Very few cases of side effects of Viraferonpeg Redi on the liver have been reported.
What is the effect of Viraferonpeg Redi on the Heart?
Very few cases of side effects of Viraferonpeg Redi on the heart have been reported.
Viraferonpeg Redi should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Viraferonpeg Redi unless your doctor advises you to do so -
Is this Viraferonpeg Redi habit forming or addictive?
No, there is no any evidence that Viraferonpeg Redi is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Viraferonpeg Redi you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Viraferonpeg Redi only on doctor's advice.
Is it able to treat mental disorders?
No, Viraferonpeg Redi cannot treat any kind of mental disorder.
Interaction between Food and Viraferonpeg Redi
It is safe to take Viraferonpeg Redi with food.
Interaction between Alcohol and Viraferonpeg Redi
Taking Viraferonpeg Redi with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pegintron® (peginterferon alfa-2b)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sylatron™ (peginterferon alfa-2b)